CoChat

Acamprosate and Prevention of Relapse in Alcoholics

Geerlings, Peter J., Ansoms, Constant, van den Brink, Wim · 1997 · European Addiction Research
Cited by 100

The DOI matches its Crossref record.

Abstract

Acamprosate is registered in the Benelux for the treatment of alcohol dependence. In a randomised, placebo-controlled, double-blind study in 262 subjects from 22 treatment centres in the Benelux countries, the effect of acamprosate as a supplement to the existing out-patient psychosocial intervention was studied on relapse after detoxification over a period of 6 months. Acamprosate had a clear positive effect on relapse prevention. Subjects in the acamprosate group completed treatment more frequently (41 vs. 31 %) and on average remained in treatment for longer (102 vs. 88 days). Patients in the acamprosate group relapsed later (after 45 vs. 15 days), were abstinent longer (61 vs. 43 days) and were more often abstinent for the entire duration of the 6-month treatment (20 vs. 10%). In the acamprosate group, 11% consumed no alcohol throughout the study period, while in the placebo group this was the case only in 5%; however, on account of the small numbers, this difference was not statistically significant. The therapeutic advantage of the acamprosate-treated patients was still present 6 months after treatment. The drug was generally well tolerated, and no serious complications occurred during the study. A major problem was the large number of subjects in both the experimental as well as the control group who did not complete treatment. It is concluded that acamprosate could be a useful adjuvant to psychosocial treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000259166

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 100

Metadata

Authors
Geerlings, P. J., Ansoms, C., & van den Brink, W.
Venue
European Addiction Research
Publisher
S. Karger AG
Published
1997
Volume
3
Issue
3
Pages
129-137
ISSN
  • 1022-6877 (ISSN-L)
  • 1421-9891
OpenAlex
W2044277361
Cited by
100
References
0
FWCI
3.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acamprosate and Prevention of Relapse in Alcoholics. https://app.cochat.ai/papers/10.1159/000259166
The paper
Geerlings, P. J., Ansoms, C., & van den Brink, W. (1997). Acamprosate and Prevention of Relapse in Alcoholics. European Addiction Research. https://doi.org/10.1159/000259166

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.